Notice of Proposed Sale · 144
Orchestra BioMed Holdings, Inc.
OBIONASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Orchestra BioMed Holdings, Inc.
- Issuer CIK
- 0001814114
- SEC file number
- 001-39421
- Phone
- 646-343-9298
- Person for whose account securities are to be sold
- Sherman Darren
- Relationships to issuer
- Officer · Director
- Street
- 150 UNION SQUARE DRIVE
- City
- NEW HOPE
- State / country code
- PA
- Postal code
- 18938
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 15,000 | 94,050.00 | 60,105,049 | 10/01/2026 | NASDAQ | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 11/25/2024 | Restricted Stock Vesting | Issuer | 15,000 | N | 11/25/2024 | Compensation |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Darren Sherman | Common | 07/01/2026 | 15,000 | 64,066.02 |
| Darren Sherman | Common | 08/03/2026 | 15,000 | 61,291.68 |
| Darren Sherman | Common | 09/01/2026 | 15,000 | 74,059.38 |
Seller — prior-sale row 1, entry 1
- Name
- Darren Sherman
- Street
- 150 Union Square Drive
- City
- New Hope
- State / country code
- PA
- Postal code
- 18938
Seller — prior-sale row 2, entry 1
- Name
- Darren Sherman
- Street
- 150 Union Square Drive
- City
- New Hope
- State / country code
- PA
- Postal code
- 18938
Seller — prior-sale row 3, entry 1
- Name
- Darren Sherman
- Street
- 150 Union Square Drive
- City
- New Hope
- State / country code
- PA
- Postal code
- 18938
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 10/01/2026
- Signed
- /s/ Margaret Campbell, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Darren Sherman
- Plan adoption dates
- 12/18/2025
Company context
Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies. The Company’s two flagship product candidates, Atrioventricular Interval Modulation (AVIM) Therapy and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB), are currently undergoing pivotal clinical trials for their lead indications, each representing multi-billion-dollar annual global market opportunities. AVIM Therapy is a bioelectronic treatment for hypertension, the leading risk factor for death worldwide, and is designed to be delivered by a pacemaker and achieve immediate, substantial and sustained reductions in blood pressure in patients with hypertensive heart disease. The Company has a strategic collaboration with Medtronic, one of the largest medical device companies in the world and the global leader in cardiac pacing therapies, for the development and commercialization of AVIM Therapy for the treatment of uncontrolled hypertension in pacemaker-indicated patients. AVIM Therapy has FDA Breakthrough Device Designations for these patients, as well as an estimated 7.7 million total patients in the U.S. with uncontrolled hypertension despite medical therapy and increased cardiovascular risk. Virtue SAB is a highly differentiated, first-of-its-kind non-coated drug delivery angioplasty balloon system designed to deliver a large liquid dose of proprietary extended-release formulation of si